Royal Bank of Canada’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$925K Buy
377,796
+361,940
+2,283% +$886K ﹤0.01% 3649
2025
Q1
$106K Buy
15,856
+7,244
+84% +$48.4K ﹤0.01% 4828
2024
Q4
$108K Sell
8,612
-5,132
-37% -$64.4K ﹤0.01% 4837
2024
Q3
$254K Buy
13,744
+4,515
+49% +$83.4K ﹤0.01% 4195
2024
Q2
$198K Buy
9,229
+5,021
+119% +$108K ﹤0.01% 4403
2024
Q1
$113K Sell
4,208
-16,431
-80% -$441K ﹤0.01% 4683
2023
Q4
$619K Buy
20,639
+9,826
+91% +$295K ﹤0.01% 3579
2023
Q3
$222K Buy
10,813
+3,579
+49% +$73.5K ﹤0.01% 4228
2023
Q2
$144K Sell
7,234
-15,631
-68% -$311K ﹤0.01% 4607
2023
Q1
$392K Buy
22,865
+12,482
+120% +$214K ﹤0.01% 3718
2022
Q4
$203K Buy
10,383
+9,850
+1,848% +$193K ﹤0.01% 4415
2022
Q3
$9K Sell
533
-18,296
-97% -$309K ﹤0.01% 5990
2022
Q2
$259K Buy
18,829
+16,296
+643% +$224K ﹤0.01% 4159
2022
Q1
$40K Sell
2,533
-6,408
-72% -$101K ﹤0.01% 5756
2021
Q4
$195K Buy
8,941
+5,532
+162% +$121K ﹤0.01% 4844
2021
Q3
$102K Buy
3,409
+689
+25% +$20.6K ﹤0.01% 5172
2021
Q2
$120K Sell
2,720
-33,166
-92% -$1.46M ﹤0.01% 5009
2021
Q1
$1.59M Buy
35,886
+35,750
+26,287% +$1.59M ﹤0.01% 2809
2020
Q4
$8K Buy
+136
New +$8K ﹤0.01% 5932
2020
Q2
Sell
-150
Closed -$2K 6282
2020
Q1
$2K Sell
150
-974
-87% -$13K ﹤0.01% 5816
2019
Q4
$26K Buy
+1,124
New +$26K ﹤0.01% 5148
2018
Q4
Sell
-635
Closed -$16K 6054
2018
Q3
$16K Sell
635
-1,106
-64% -$27.9K ﹤0.01% 5176
2018
Q2
$34K Sell
1,741
-653
-27% -$12.8K ﹤0.01% 4737
2018
Q1
$45K Buy
+2,394
New +$45K ﹤0.01% 4501
2017
Q4
Sell
-5
Closed 5976
2017
Q3
$0 Buy
+5
New ﹤0.01% 6077
2017
Q2
Sell
-659
Closed -$5K 5911
2017
Q1
$5K Buy
659
+22
+3% +$167 ﹤0.01% 5532
2016
Q4
$15K Buy
637
+382
+150% +$9K ﹤0.01% 5159
2016
Q3
$9K Buy
+255
New +$9K ﹤0.01% 5056